脂质体布比卡因肌间沟臂丛阻滞联合艾司氯胺酮持续输注对肩袖修复术后恢复质量的影响:随机对照试验研究方案
本研究为单中心随机对照试验,计划纳入278例关节镜下肩袖修复术患者,1:1随机分为干预组(超声引导下脂质体布比卡因肌间沟臂丛阻滞+艾司氯胺酮持续静脉输注)和对照组(生理盐水输注)。主要结局为术后24小时QoR-15评分,旨在评估该联合方案对术后恢复质量的协同效应。
要点
- 脂质体布比卡因肌间沟臂丛阻滞可提供长达72小时持续镇痛。
- 联合艾司氯胺酮输注可能通过增强镇痛、稳定情绪和认知支持进一步获益。
- 主要结局为术后24小时QoR-15评分,涵盖疼痛、舒适度、独立性和心理状态。
核心结论
- 该研究方案拟评估脂质体布比卡因肌间沟臂丛阻滞联合艾司氯胺酮持续输注对关节镜下肩袖修复术后恢复质量的协同效应。
研究设计与样本
- 单中心随机对照试验,计划纳入278例关节镜下肩袖修复术患者,按1:1比例随机分配至干预组或对照组。
- 干预组接受超声引导下脂质体布比卡因肌间沟臂丛阻滞联合艾司氯胺酮持续静脉输注,对照组接受生理盐水输注。
关键数值与推荐
- 主要结局为术后24小时QoR-15评分。
- 次要结局包括30天内各时间点QoR-15评分、疼痛评分、总阿片类药物消耗量、补救镇痛需求、术后谵妄发生率、医院焦虑抑郁量表评分、睡眠质量、住院时间及不良事件。
临床怎么用
- 该联合方案以加速康复外科(ERAS)原则为指导,通过QoR-15量表评估患者报告的恢复质量,涵盖疼痛、身体舒适度、独立性和心理幸福感。
- 作为单中心研究,其结果可为该多模式策略提供初步证据。
局限性
- 单中心设计可能限制结果的普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Arthroscopic rotator cuff repair is the standard of care for rotator cuff tears. However, postoperative pain and recovery remain a significant clinical challenge. While ultrasound-guided interscalene brachial plexus block with liposomal bupivacaine provides sustained analgesia for up to 72 h, the addition of esketamine intravenous infusion may offer further benefits through enhanced pain control, mood stabilization, and cognitive support. This study aims to evaluate the synergistic effect of this combination on the quality of postoperative recovery in patients undergoing arthroscopic rotator cuff repair. METHODS: This single center, randomized controlled trial will enroll 278 patients undergoing arthroscopic rotator cuff repair. Participants will be randomly allocated at a 1:1 ratio to either the intervention or control group. The intervention group will receive a combination of an ultrasound-guided interscalene brachial plexus block with liposomal bupivacaine and a continuous intravenous esketamine infusion, while the control group will receive a saline infusion. The primary outcome is the 15-item Quality of Recovery (QoR-15) score at 24 h postoperatively. Secondary outcomes include QoR-15 scores at various time points within 30 days, pain scores, total opioid consumption, need for rescue analgesia, incidence of postoperative delirium, hospital anxiety and depression scale scores, sleep quality, length of hospital stay, and adverse events. DISCUSSION: Guided by Enhanced Recovery After Surgery principles, this randomized controlled trial investigates a novel combination of liposomal bupivacaine block and esketamine infusion to enhance postoperative recovery after arthroscopic rotator cuff repair. It specifically assesses patient-reported recovery through the QoR-15 score, a validated tool encompassing pain, physical comfort, independence, and psychological well-being. As a single-center initiative, this work represents a pivotal step in generating preliminary evidence for this multimodal strategy. TRIAL REGISTRATION: This study has been approved by the Ethics Committee at West China Hospital, Sichuan University (approval no. 2025-1908). The trial was prospectively registered with the Chinese Clinical Trial Registry (ChiCTR2500112854) on November 20, 2025.
引用
- Yue J, Wang Q, Tang Q, et al. Effect of ultrasound-guided interscalene brachial plexus block using liposome bupivacaine combined with continuous esketamine infusion on quality of recovery in patients undergoing arthroscopic rotator cuff repair: study protocol for a randomized controlled trial. Trials. 2026. PMID: 42121214. doi:10.1186/s13063-026-09784-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。